Open access
Open access
Powered by Google Translator Translator

Cohort Study: SLGT2 Inhibitors Linked to Lower Risk of Renal Events in Patients with Type 2 Diabetes

7 May, 2020 | 08:57h | UTC

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study – The BMJ

Editorial: SGLT2 inhibitors and kidney outcomes in the real world

Commentary: Certain diabetes drugs may protect against serious kidney problems – The BMJ

Related Analysis: Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators – The BMJ

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.